Mantle cell lymphomaBTK inhibitorsnovel therapieschemotherapy-freetargeted therapiesHIGH-DOSE CYTARABINEPLUS RITUXIMABOPEN-LABELINITIAL TREATMENTSINGLE-ARMMantle cell lymphoma (MCL) primarily affects older adults, accounting for 3-10% of all non-Hodgkin lymphoma (NHL) in western countries. The disease ...
Mantle cell lymphoma (MCL) predominantly affects older adults, with a median age at diagnosis of 70 years. A frequently aggressive yet incurable lymphoma, the goal of therapy for MCL is to turn a potentially life-threatening illness into a chronic disease with prolonged periods of remission. Larg...
InnoCare Pharma announced that HIBRUKA has been approved by the Health Sciences Authority of Singapore for the treatment of adult patients with relapsed or refractory mantle cell lymphoma. BEIJING--(BUSINESS WIRE)-- InnoCare Pharma (HKEX: 09969; SSE: 688428),...
Current Treatment Approaches for Mantle Cell Lymphoma. J Clin Oncol. 2005; 23 :6409–6414.Witzig TE. Current treatment approaches for mantle-cell lymphoma. J Clin Oncol 2005; 23: 6409-14. http://dx.doi.org/10.1200/JCO.2005.55.017Witzig TE. Current treatment approaches for mantle-cell ly...
Mantle cell lymphoma is a rare form of B-cell non-Hodgkin lymphoma. It is a type of blood cancer that affects white blood cells called lymphocytes.
Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses the evolution of treatment in mantle cell lymphoma (MCL). Physicians have made significant progress in the treatment of patients with MCL, says Goy, but states that there is a ...
Using a microscope, experts will look at the sample to see if there are cancer cells. They also test the tissue for cell changes and other signs that point to mantle cell lymphoma. Your doctor may also take samples of your bone marrow, usually from your hip bone, to see if the cancer...
The overall survival of mantle cell lymphoma virtually doubled in the recent 10 years as a result of two key factors: 1. optimization of frontline therapy with "conventional" antilymphoma agents, and 2. brand new possibilities of therapy for R/ R mantle cell lymphoma thanks to the ...
scientists from Uppsala University and other Swedish universities show that people with mantle cell lymphoma who were unmarried, and those who had low educational attainment, were less often treated with a stem-cell transplantation, which may result in poorer survival. The findings...
by Barbara Williams A new drug has been approved to battle mantle cell lymphoma, an aggressive cancer often fatal because of its resistance to treatment, after a study led by a Hackensack University Medical Center physician showed it can stop the progression of the disease in about a quarter of...